company background image
1612

Vincent Medical Holdings SEHK:1612 Stock Report

Last Price

HK$0.72

Market Cap

HK$470.4m

7D

-2.7%

1Y

-64.9%

Updated

25 May, 2022

Data

Company Financials +
1612 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends3/6

1612 Stock Overview

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices.

Vincent Medical Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vincent Medical Holdings
Historical stock prices
Current Share PriceHK$0.72
52 Week HighHK$2.29
52 Week LowHK$0.65
Beta-0.27
1 Month Change-6.49%
3 Month Change-14.29%
1 Year Change-64.88%
3 Year Change10.77%
5 Year Change-20.88%
Change since IPO-23.40%

Recent News & Updates

Apr 27
Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Vincent Medical Holdings Limited ( HKG:1612 ) is reducing its dividend to HK$0.025 on the 24th of June. The dividend...

Apr 07
Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year

Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year

Vincent Medical Holdings Limited ( HKG:1612 ) is reducing its dividend to HK$0.025 on the 24th of June. The dividend...

Shareholder Returns

1612HK Medical EquipmentHK Market
7D-2.7%-3.5%-1.0%
1Y-64.9%-68.0%-26.1%

Return vs Industry: 1612 exceeded the Hong Kong Medical Equipment industry which returned -68% over the past year.

Return vs Market: 1612 underperformed the Hong Kong Market which returned -26.1% over the past year.

Price Volatility

Is 1612's price volatile compared to industry and market?
1612 volatility
1612 Average Weekly Movement6.7%
Medical Equipment Industry Average Movement9.8%
Market Average Movement8.0%
10% most volatile stocks in HK Market15.1%
10% least volatile stocks in HK Market3.9%

Stable Share Price: 1612 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 1612's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,281To Ki Cheunghttps://www.vincentmedical.com

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers.

Vincent Medical Holdings Fundamentals Summary

How do Vincent Medical Holdings's earnings and revenue compare to its market cap?
1612 fundamental statistics
Market CapHK$470.40m
Earnings (TTM)HK$60.70m
Revenue (TTM)HK$777.72m

7.8x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1612 income statement (TTM)
RevenueHK$777.72m
Cost of RevenueHK$518.62m
Gross ProfitHK$259.10m
Other ExpensesHK$198.41m
EarningsHK$60.70m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.093
Gross Margin33.32%
Net Profit Margin7.80%
Debt/Equity Ratio9.2%

How did 1612 perform over the long term?

See historical performance and comparison

Dividends

6.9%

Current Dividend Yield

49%

Payout Ratio

Does 1612 pay a reliable dividends?

See 1612 dividend history and benchmarks
When do you need to buy 1612 by to receive an upcoming dividend?
Vincent Medical Holdings dividend dates
Ex Dividend DateMay 27 2022
Dividend Pay DateJun 24 2022
Days until Ex dividend1 day
Days until Dividend pay date29 days

Does 1612 pay a reliable dividends?

See 1612 dividend history and benchmarks

Valuation

Is Vincent Medical Holdings undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


47.9%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 1612 (HK$0.72) is trading below our estimate of fair value (HK$1.38)

Significantly Below Fair Value: 1612 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 1612 is good value based on its Price-To-Earnings Ratio (7.8x) compared to the Hong Kong Medical Equipment industry average (14.4x).

PE vs Market: 1612 is good value based on its Price-To-Earnings Ratio (7.8x) compared to the Hong Kong market (8.7x).


Price to Earnings Growth Ratio

PEG Ratio: 1612 is poor value based on its PEG Ratio (1.7x)


Price to Book Ratio

PB vs Industry: 1612 is good value based on its Price-To-Book Ratio (0.8x) compared to the HK Medical Equipment industry average (1.3x).


Future Growth

How is Vincent Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


4.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1612's forecast earnings growth (4.6% per year) is above the savings rate (1.5%).

Earnings vs Market: 1612's earnings (4.6% per year) are forecast to grow slower than the Hong Kong market (16.1% per year).

High Growth Earnings: 1612's earnings are forecast to grow, but not significantly.

Revenue vs Market: 1612's revenue (4.5% per year) is forecast to grow slower than the Hong Kong market (9.8% per year).

High Growth Revenue: 1612's revenue (4.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1612's Return on Equity is forecast to be low in 3 years time (12.4%).


Past Performance

How has Vincent Medical Holdings performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


45.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 1612 has high quality earnings.

Growing Profit Margin: 1612's current net profit margins (7.8%) are lower than last year (18.8%).


Past Earnings Growth Analysis

Earnings Trend: 1612's earnings have grown significantly by 45.7% per year over the past 5 years.

Accelerating Growth: 1612's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1612 had negative earnings growth (-72%) over the past year, making it difficult to compare to the Medical Equipment industry average (35.4%).


Return on Equity

High ROE: 1612's Return on Equity (10%) is considered low.


Financial Health

How is Vincent Medical Holdings's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 1612's short term assets (HK$640.8M) exceed its short term liabilities (HK$232.8M).

Long Term Liabilities: 1612's short term assets (HK$640.8M) exceed its long term liabilities (HK$12.9M).


Debt to Equity History and Analysis

Debt Level: 1612 has more cash than its total debt.

Reducing Debt: 1612's debt to equity ratio has increased from 1.1% to 9.2% over the past 5 years.

Debt Coverage: 1612's debt is well covered by operating cash flow (215.5%).

Interest Coverage: 1612's interest payments on its debt are well covered by EBIT (42.6x coverage).


Balance Sheet


Dividend

What is Vincent Medical Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


6.94%

Current Dividend Yield

Upcoming Dividend Payment

TodayMay 25 2022Ex Dividend DateMay 27 2022Dividend Pay DateJun 24 202228 days from Ex DividendBuy in the next 1 day to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 1612's dividend (6.94%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.89%).

High Dividend: 1612's dividend (6.94%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.84%).


Stability and Growth of Payments

Stable Dividend: 1612 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 1612's dividend payments have increased, but the company has only paid a dividend for 5 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (48.5%), 1612's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (34.7%), 1612's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

To Ki Cheung (54 yo)

no data

Tenure

HK$1,698,000

Compensation

Mr. To Ki Cheung serves as Director at Inovytec Medical Solutions Ltd. He serves as Chief Executive Officer and General Manager at Vincent Medical Holdings Limited and has been its Executive Director Novem...


CEO Compensation Analysis

Compensation vs Market: To Ki's total compensation ($USD216.32K) is about average for companies of similar size in the Hong Kong market ($USD234.81K).

Compensation vs Earnings: To Ki's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 1612's management team is considered experienced (2.7 years average tenure).


Board Members

Experienced Board: 1612's board of directors are considered experienced (6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 1612 insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Vincent Medical Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Vincent Medical Holdings Limited
  • Ticker: 1612
  • Exchange: SEHK
  • Founded: 1997
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: HK$470.402m
  • Shares outstanding: 653.34m
  • Website: https://www.vincentmedical.com

Number of Employees


Location

  • Vincent Medical Holdings Limited
  • Units 1604-07A
  • 16th Floor
  • Hung Hom
  • Kowloon
  • Hong Kong

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/25 00:00
End of Day Share Price2022/05/25 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.